Hindustan Foods Ltd Q1 FY26 – Revenue ₹995 Cr, PAT ₹31.7 Cr, EPS ₹2.66. Debt at ₹892 Cr: Contract Manufacturing or Contractual Gym Membership?
1. At a Glance
Hindustan Foods Limited (HFL) is like that over-enthusiastic kid in school who signs up for dance, cricket, robotics, and debate—only to collapse during the annual day. One quarter they’re churning Pepsi snacks, next quarter they’re making Bata shoes, and by evening they’re bottling pharma creams. Q1 FY26 revenue grew 14.6% YoY to ₹995 Cr, profit jumped 16.4% to ₹31.7 Cr, and debt stands like a nosy landlord at ₹892 Cr. Diversification looks sexy in investor presentations, but ask any auditor—the real spice is whether margins are paying for this buffet.
2. Introduction
Once upon a time, Hindustan Foods was a boring joint venture manufacturing Farex baby food for GlaxoSmithKline. But like every Indian joint venture, it ended in “yeh shaadi nahin chal sakti.”
Enter Vanity Case (yes, that’s literally the name—sounds more like a Bandra makeup shop than a promoter group). They took over in 2013 and said, “Arre baba, why be loyal to one client? Let’s become the Tinder of contract manufacturing—swipe right on every FMCG brand willing to outsource production.”
Fast forward to FY26: HFL has 11 plants across India, 85% of revenue tied up in “Dedicated Manufacturing” (aka glorified long leases where one plant is hostage to one FMCG giant). They’ve added pharma, shoes, ice cream, and maybe next year they’ll announce contract manufacturing of iPhones.
Margins? 8%. P/E? 57. Debt? ₹892 Cr. Promoter holding falling slowly like my hairline. But hey, they have clients like HUL, PepsiCo, Wipro, and Bata, so at least the brand list looks like a Shaadi.com profile.
Question for you, dear reader: would you trust a company making your favourite chips, your shampoo, your shoes, AND your cough syrup—under the same umbrella?
3. Business Model – WTF Do They Even Do?
HFL has three distinct models of making money (other than playing musical chairs with plants):
Dedicated Manufacturing (85% of revenue) – A plant is dedicated to one client. Example: a full factory for HUL detergents. Stable, but renewal risk is like your landlord raising rent every 11 months.
Shared Manufacturing – Think of Goa plant, which makes extruded foods for Pepsi, Danone, Marico. This is basically a co-working space for FMCG giants, with Maggi instead of free WiFi.
Private Label Manufacturing – Here, HFL owns the formula and sells turnkey solutions. This is the real money-spinner because margins aren’t controlled by the client. Example: Bonny Mix (porridge), Cnergy (cereal), Unorthodox (shoes). The names sound like rejected Netflix shows, but profitability is higher.
And then, the “bonus tracks”: pharma creams from their Baddi unit, leather shoes, sports shoe components via KNS Shoetech, and a brand-new ice cream plant in Haryana. Essentially, if it can be packaged, HFL wants to make it.
But the real audit question: are they manufacturers or glorified landlords of plants?
4. Financials Overview
Here’s the quarter-by-quarter scorecard:
Source table
Metric
Latest Qtr (Q1 FY26)
YoY Qtr (Q1 FY25)
Prev Qtr (Q4 FY25)
YoY %
QoQ %
Revenue
995
868
933
14.6%
6.6%
EBITDA
80
73
77
9.6%
3.9%
PAT
31.7
27.2
32.0
16.4%
-0.9%
EPS (₹)
2.66
2.38
2.62
11.8%
1.5%
Commentary: YoY growth is decent. QoQ is flat like my office AC during summer—PAT even fell slightly. EPS annualised = ₹10.6. With CMP at ₹550, that’s a P/E of ~52. FMCG giants like HUL have margins of 20%+; HFL gets 8%. It’s like being the caterer at Ambani’s wedding—you work hard, but the guests get all the glory.
5. Valuation Discussion – Fair Value Range
Let’s torture the numbers auditor-style:
P/E method: Annualised EPS ~₹10.6. Industry P/E ~52. → Range = 40x to 55x = ₹424 to ₹583.
EV/EBITDA method: TTM EBITDA ~₹300 Cr. EV ~₹7,386 Cr. → EV/EBITDA = 24.6. Industry range = 18–24. → Fair EV = 18×300 to
